Yes, it's Trump's fault
L'Oreal says weight loss drugs are impacting beauty and skin care sales
The beauty giant's CEO says the use of GLP-1s is "a very important phenomenon for us."
L'Oreal says weight loss drugs are impacting beauty and skin care sales
POLL
Voting on: L'Oreal says weight loss drugs are impacting beauty and skin care sales
Poll
All Responses
Hung jury.
Yes, it's Trump's fault
No, it's not Trump's fault
Too soon to tell
0 verified votes
Yes, it's Trump's fault
The beauty giant's CEO says the use of GLP-1s is "a very important phenomenon for us."
No, it's not Trump's fault
The beauty giant's CEO says the use of GLP-1s is "a very important phenomenon for us."
Read what happened. Then watch the spinning begin. Facts first
Real event · international · 2026-10-22
Final verdict announced: October 23, 2026 at 8:02 PM ET
L'Oreal says weight loss drugs are impacting beauty and skin care sales
The beauty giant's CEO says the use of GLP-1s is "a very important phenomenon for us."
The documented connection: No documented connection · Authority: personal
The CEO's statement highlights the impact of weight loss drugs.
Original reporting
Companion sites publish satirical readings of this record. Neither is the news.